Fundamentals Hub
AVAI AVAI BIO, INC.
AVAI financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 8 annual and 0 of 32 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$36.85M (Mar 2026)
Industry (SIC)
7374 Services-Computer Processing & Data Preparation
Incorporated
NV
Fiscal Year End
March (0331)
Phone
866-533-0065
EIN
384053064
Headquarters
LAS VEGAS, NV, 89108
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
AVANT TECHNOLOGIES INC. (2023–2026)
· TREND INNOVATIONS HOLDING INC. (2020–2023)
· FREECOOK (2018–2020)
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
$-2.79M
Total Assets
$791.75K
Total Equity
$-3.22M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
86.6%
Return on Assets
-352.3%
Current Ratio
0.04x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2026 📄 | FY2025 📄 | FY2024 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| R&D Expense | $15.00K | - | - |
| SG&A Expense | $792.27K | $762.48K | $1.42M |
| Operating Income | $-1.75M | $-1.14M | $-2.13M |
| NON-OPERATING INCOME / EXPENSE | |||
| Other Income/Expense | - | - | $-11.29K |
| Net Income | $-1.75M | $-1.14M | $-2.13M |
| PER SHARE & SUPPLEMENTAL | |||
| EBITDA | $-1.72M | $-1.07M | $-2.05M |
| Depreciation & Amortization | $26.07K | $74.32K | $76.95K |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $23.15K | $81.05K | $281 |
| Other Current Assets | $6.10K | $12.08K | $115.69K |
| Current Assets | $89.34K | $93.13K | $116.08K |
| PP&E (Net) | $1.50K | - | $1.50K |
| Intangible Assets | $105.54K | $131.61K | $205.93K |
| Other Noncurrent Assets | $377.81K | $131.61K | - |
| Noncurrent Assets | $483.36K | $131.61K | $205.93K |
| Total Assets | $572.70K | $224.75K | $322.01K |
| LIABILITIES | |||
| Accounts Payable | $1.59M | $885.27K | $1.08M |
| Short-term Debt | $24.92K | $30.00K | - |
| Other Current Liabilities | $744.42K | $512.08K | $406.78K |
| Current Liabilities | $3.39M | $1.79M | $1.79M |
| Noncurrent Liabilities | $0 | $0 | $0 |
| Total Liabilities | $3.39M | $1.79M | $1.79M |
| EQUITY | |||
| Common Stock | $153.21K | $137.36K | $117.17K |
| Additional Paid-in Capital | $2.87M | $2.39M | $1.37M |
| Retained Earnings | $-5.87M | $-4.12M | $-2.98M |
| Total Equity | $-2.82M | $-1.56M | $-1.47M |
| Total Liabilities & Equity | $572.70K | $224.75K | $322.01K |
| SUPPLEMENTAL | |||
| Shares Outstanding | 153.21M | 137.36M | 117.17M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-1.01M | $-1.16M | $-1.32M |
| Capital Expenditures | - | - | - |
| Cash from Investing | $0 | $0 | $-149.00K |
| Cash from Financing | $951.94K | $1.24M | $1.36M |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $81.05K | $281 | $107.47K |
| Net Change in Cash | $-57.91K | $80.77K | $-107.19K |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $23.15K | $81.05K | $281 |
| Cash per BS | $23.15K | $81.05K | $281 |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $23.15K | $81.05K | $281 |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is AVAI BIO, INC. profitable?
No. AVAI BIO, INC. reported $-2.79M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.